| 12485157 |
Method of treating COVID-19 |
Robert Louis Hoffman, Robert Steven Kania, Dafydd Rhys Owen, Markus Pettersson, Matthew Forrest Sammons |
2025-12-02 |
|
| 12358897 |
Compounds and method of treating COVID-19 |
Robert Steven Kania, Dafydd Rhys Owen, Martin Youngjin Pettersson, Matthew Forrest Sammons |
2025-07-15 |
|
| 11926642 |
Compounds and methods for the treatment of COVID-19 |
Robert Steven Kania, Padmavani Bezawada, Emma Louise Hawking, Rohit Jaini, Samir Kulkarni +11 more |
2024-03-12 |
$461,539,000 |
| 11684616 |
Azalactam compounds as HPK1 inhibitors |
Joyann Barber, Sujin Cho-Schultz, Matthew L. Del Bel, Rebecca Anne Gallego, Mingying He +7 more |
2023-06-27 |
$1,063,981,000 |
| 11541034 |
Nitrile-containing antiviral compounds |
Dafydd Rhys Owen, Martin Youngjin Pettersson, Matthew Richard Reese, Matthew Forrest Sammons, Patrick Robert Verhoest +3 more |
2023-01-03 |
$607,007,000 |
| 11452711 |
Nitrile-containing antiviral compounds |
Dafydd Rhys Owen, Matthew Richard Reese, Matthew Forrest Sammons, Patrick Robert Verhoest, Qingyi Yang |
2022-09-27 |
$2,026,453,000 |
| 11390623 |
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands |
Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos +4 more |
2022-07-19 |
$2,227,040,000 |
| 11351149 |
Nitrile-containing antiviral compounds |
Dafydd Rhys Owen, Martin Youngjin Pettersson, Matthew Richard Reese, Matthew Forrest Sammons, Patrick Robert Verhoest +3 more |
2022-06-07 |
$2,438,741,000 |
| 11142525 |
Azalactam compounds as HPK1 inhibitors |
Rebecca Anne Gallego, Sajiv Krishnan Nair, Robert Steven Kania, Omar Khaled Ahmad, Ted William Johnson +7 more |
2021-10-12 |
$1,305,497,000 |
| 10590128 |
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands |
Thomas Allen Chappie, Jaclyn Louise Henderson, Joseph Michael Young, Travis T. Wager, Bethany Lyn Kormos +4 more |
2020-03-17 |
$194,251,000 |
| 9296761 |
Triazine derivatives |
Thomas Allen Chappie, Christopher John Helal, Bethany Lyn Kormos, Patrick Robert Verhoest |
2016-03-29 |
$310,571,000 |
| 8933224 |
Triazine derivatives |
Thomas Allen Chappie, Christopher John Helal, Bethany Lyn Kormos, Patrick Robert Verhoest |
2015-01-13 |
$137,387,000 |
| 8487104 |
KAT II inhibitors |
Amy Beth Dounay, Christopher John Helal, Patrick Robert Verhoest |
2013-07-16 |
$331,538,000 |
| 8183238 |
Bicyclic and tricyclic compounds as KAT II inhibitors |
Michelle Marie Claffey, Amy Beth Dounay, Matthew Merrill Hayward, Suobao Rong, Patrick Robert Verhoest +1 more |
2012-05-22 |
$139,115,000 |
| 7323604 |
Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalysts |
David MacMillan, Stephane Ouellet |
2008-01-29 |
|
